Andy Chen

Andy Chen Analyst Performance

Senior Analyst at Wolfe Research

Andy Chen is a stock analyst at Wolfe Research in the healthcare sector, covering 28 publicly traded companies. Over the past year, Andy Chen has issued 25 stock ratings, including strong buy, buy, hold, and sell recommendations. While full access to Andy Chen's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Andy Chen's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
51 Last 2 Years
Buy Recommendations
62.00% 31 Buy Ratings
Companies Covered
28 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy8.0%4 ratings
Buy54.0%27 ratings
Hold34.0%17 ratings
Sell4.0%2 ratings

Out of 50 total stock ratings issued by Andy Chen at Wolfe Research, the majority (54.0%) have been Buy recommendations, followed by 34.0% Hold, 8.0% Strong Buy, and 4.0% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
28 companies

Andy Chen, an analyst at Wolfe Research, currently covers 28 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
28 companies
100.0%

Andy Chen of Wolfe Research specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
26 companies
92.9%
PHARMACEUTICALS
2 companies
7.1%

Andy Chen's Ratings History at Wolfe Research

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
10/12/2026Downgrade$35.44Peer Perform
Insmed, Inc. stock logo
INSM
Insmed
10/12/2026Downgrade$100.60Peer Perform
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
9/10/2026Upgrade$115.43$180.00Outperform
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
8/4/2026Upgrade$482.00$605.00Outperform
Spyre Therapeutics, Inc. stock logo
SYRE
Spyre Therapeutics
7/28/2026Downgrade$100.04Peer Perform
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
7/16/2026Downgrade$54.73Peer Perform
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
7/15/2026Downgrade$13.04$9.00Underperform
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
7/9/2026Upgrade$20.21$27.00Outperform
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
6/10/2026Reiterated Rating$76.78Outperform
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
4/9/2026Initiated Coverage$14.41$48.00Outperform
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
4/9/2026Initiated Coverage$87.48$98.00Outperform
Palisade Bio, Inc. stock logo
PALI
Palisade Bio
4/9/2026Initiated Coverage$1.87$7.00Outperform
Pharvaris N.V. stock logo
PHVS
Pharvaris
4/9/2026Initiated Coverage$27.56$42.00Outperform
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
4/8/2026Initiated Coverage$14.21$48.00Outperform
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
4/8/2026Upgrade$91.66Strong-Buy
Palisade Bio, Inc. stock logo
PALI
Palisade Bio
4/8/2026Initiated Coverage$1.98$7.00Outperform
Pharvaris N.V. stock logo
PHVS
Pharvaris
4/8/2026Initiated Coverage$27.07$42.00Outperform
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
3/23/2026Upgrade$16.27$24.00Outperform
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
3/11/2026Upgrade$40.25$88.00Outperform
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
1/7/2026Initiated Coverage$78.25Peer Perform
Immunovant, Inc. stock logo
IMVT
Immunovant
1/6/2026Upgrade$24.97$50.00Outperform
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
1/6/2026Set Price Target$588.40$579.00
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
1/6/2026Upgrade$448.80$548.00Outperform
Insmed, Inc. stock logo
INSM
Insmed
12/18/2025Set Price Target$198.46$167.00Outperform
argenex SE stock logo
ARGX
argenex
11/24/2025Reiterated Rating$918.92Peer Perform
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
11/12/2025Reiterated Rating$10.18Peer Perform
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
11/6/2025Initiated Coverage$19.95Peer Perform
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
10/10/2025Downgrade$54.08Hold
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
8/4/2025Upgrade$401.80Peer Perform
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
8/4/2025Reiterated Rating$20.95Peer Perform
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
6/17/2025Initiated Coverage$29.80$55.00Outperform
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
6/17/2025Initiated Coverage$41.14$49.00Outperform
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
6/17/2025Initiated Coverage$20.94Peer Perform
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
5/19/2025Upgrade$37.62$61.00Outperform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
5/7/2025Downgrade$442.75Peer Perform
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
4/21/2025Upgrade$7.23$21.00Outperform
Spyre Therapeutics, Inc. stock logo
SYRE
Spyre Therapeutics
3/18/2025Initiated Coverage$18.54$27.00Outperform
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
2/4/2025Initiated Coverage$16.66$25.00Outperform
Crinetics Pharmaceuticals, Inc. stock logo
CRNX
Crinetics Pharmaceuticals
2/4/2025Initiated Coverage$38.79Peer Perform
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
2/4/2025Initiated Coverage$13.70$20.00Outperform
A $247 tool for $7 (Ad)

Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full year, with no re-bills and nothing to install. The catch? He isn't trying to profit on the scanner itself. Poulos is betting that once you see it deliver the night's list, you'll want more of his work for years.tc pixel

See the Instant Scanner in action and claim the $7 Black Friday deal today.
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
2/4/2025Initiated Coverage$36.54$49.00Outperform
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
2/3/2025Upgrade$16.51Strong-Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
2/3/2025Upgrade$14.21Strong-Buy
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
2/3/2025Upgrade$38.07Strong-Buy
Immunovant, Inc. stock logo
IMVT
Immunovant
1/3/2025Downgrade$25.19Peer Perform